161 related articles for article (PubMed ID: 22952725)
1. Biochemical and functional studies of lymphoid-specific tyrosine phosphatase (Lyp) variants S201F and R266W.
Liu J; Chen M; Li R; Yang F; Shi X; Zhu L; Wang HM; Yao W; Liu Q; Meng FG; Sun JP; Pang Q; Yu X
PLoS One; 2012; 7(8):e43631. PubMed ID: 22952725
[TBL] [Abstract][Full Text] [Related]
2. Structure, inhibitor, and regulatory mechanism of Lyp, a lymphoid-specific tyrosine phosphatase implicated in autoimmune diseases.
Yu X; Sun JP; He Y; Guo X; Liu S; Zhou B; Hudmon A; Zhang ZY
Proc Natl Acad Sci U S A; 2007 Dec; 104(50):19767-72. PubMed ID: 18056643
[TBL] [Abstract][Full Text] [Related]
3. A loss-of-function variant of PTPN22 is associated with reduced risk of systemic lupus erythematosus.
Orrú V; Tsai SJ; Rueda B; Fiorillo E; Stanford SM; Dasgupta J; Hartiala J; Zhao L; Ortego-Centeno N; D'Alfonso S; ; Arnett FC; Wu H; Gonzalez-Gay MA; Tsao BP; Pons-Estel B; Alarcon-Riquelme ME; He Y; Zhang ZY; Allayee H; Chen XS; Martin J; Bottini N
Hum Mol Genet; 2009 Feb; 18(3):569-79. PubMed ID: 18981062
[TBL] [Abstract][Full Text] [Related]
4. Lymphoid-specific tyrosine phosphatase (Lyp): a potential drug target for treatment of autoimmune diseases.
Du J; Qiao Y; Sun L; Wang X
Curr Drug Targets; 2014 Mar; 15(3):335-46. PubMed ID: 24188455
[TBL] [Abstract][Full Text] [Related]
5. Identification and structure-function analyses of an allosteric inhibitor of the tyrosine phosphatase PTPN22.
Li K; Hou X; Li R; Bi W; Yang F; Chen X; Xiao P; Liu T; Lu T; Zhou Y; Tian Z; Shen Y; Zhang Y; Wang J; Fang H; Sun J; Yu X
J Biol Chem; 2019 May; 294(21):8653-8663. PubMed ID: 30979725
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune-associated PTPN22 R620W variation reduces phosphorylation of lymphoid phosphatase on an inhibitory tyrosine residue.
Fiorillo E; Orrú V; Stanford SM; Liu Y; Salek M; Rapini N; Schenone AD; Saccucci P; Delogu LG; Angelini F; Manca Bitti ML; Schmedt C; Chan AC; Acuto O; Bottini N
J Biol Chem; 2010 Aug; 285(34):26506-18. PubMed ID: 20538612
[TBL] [Abstract][Full Text] [Related]
7. The autoimmune-predisposing variant of lymphoid tyrosine phosphatase favors T helper 1 responses.
Vang T; Landskron J; Viken MK; Oberprieler N; Torgersen KM; Mustelin T; Tasken K; Tautz L; Rickert RC; Lie BA
Hum Immunol; 2013 May; 74(5):574-85. PubMed ID: 23333624
[TBL] [Abstract][Full Text] [Related]
8. Gold(I) phosphine mediated selective inhibition of lymphoid tyrosine phosphatase.
Karver MR; Krishnamurthy D; Bottini N; Barrios AM
J Inorg Biochem; 2010 Mar; 104(3):268-73. PubMed ID: 20083307
[TBL] [Abstract][Full Text] [Related]
9. Target-specific control of lymphoid-specific protein tyrosine phosphatase (Lyp) activity.
Walton ZE; Bishop AC
Bioorg Med Chem; 2010 Jul; 18(14):4884-91. PubMed ID: 20594861
[TBL] [Abstract][Full Text] [Related]
10. Identification of a variant form of tyrosine phosphatase LYP.
Wang S; Dong H; Han J; Ho WT; Fu X; Zhao ZJ
BMC Mol Biol; 2010 Nov; 11():78. PubMed ID: 21044313
[TBL] [Abstract][Full Text] [Related]
11. Substrate specificity of lymphoid-specific tyrosine phosphatase (Lyp) and identification of Src kinase-associated protein of 55 kDa homolog (SKAP-HOM) as a Lyp substrate.
Yu X; Chen M; Zhang S; Yu ZH; Sun JP; Wang L; Liu S; Imasaki T; Takagi Y; Zhang ZY
J Biol Chem; 2011 Sep; 286(35):30526-30534. PubMed ID: 21719704
[TBL] [Abstract][Full Text] [Related]
12. The lymphoid protein tyrosine phosphatase Lyp interacts with the adaptor molecule Grb2 and functions as a negative regulator of T-cell activation.
Hill RJ; Zozulya S; Lu YL; Ward K; Gishizky M; Jallal B
Exp Hematol; 2002 Mar; 30(3):237-44. PubMed ID: 11882361
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of lymphoid tyrosine phosphatase by benzofuran salicylic acids.
Vang T; Xie Y; Liu WH; Vidović D; Liu Y; Wu S; Smith DH; Rinderspacher A; Chung C; Gong G; Mustelin T; Landry DW; Rickert RC; Schürer SC; Deng SX; Tautz L
J Med Chem; 2011 Jan; 54(2):562-71. PubMed ID: 21190368
[TBL] [Abstract][Full Text] [Related]
14. LYP inhibits T-cell activation when dissociated from CSK.
Vang T; Liu WH; Delacroix L; Wu S; Vasile S; Dahl R; Yang L; Musumeci L; Francis D; Landskron J; Tasken K; Tremblay ML; Lie BA; Page R; Mustelin T; Rahmouni S; Rickert RC; Tautz L
Nat Chem Biol; 2012 Mar; 8(5):437-46. PubMed ID: 22426112
[TBL] [Abstract][Full Text] [Related]
15. The putative role of the C1858T polymorphism of protein tyrosine phosphatase PTPN22 gene in autoimmunity.
Gianchecchi E; Palombi M; Fierabracci A
Autoimmun Rev; 2013 May; 12(7):717-25. PubMed ID: 23261816
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of the
Perry DJ; Peters LD; Lakshmi PS; Zhang L; Han Z; Wasserfall CH; Mathews CE; Atkinson MA; Brusko TM
J Immunol; 2021 Aug; 207(3):849-859. PubMed ID: 34301848
[TBL] [Abstract][Full Text] [Related]
17. [Research progress of several protein tyrosine phosphatases in diabetes].
Chen M; Sun JP; Liu J; Yu X
Sheng Li Xue Bao; 2010 Apr; 62(2):179-89. PubMed ID: 20401454
[TBL] [Abstract][Full Text] [Related]
18. Regulation of lymphoid tyrosine phosphatase activity: inhibition of the catalytic domain by the proximal interdomain.
Liu Y; Stanford SM; Jog SP; Fiorillo E; Orrú V; Comai L; Bottini N
Biochemistry; 2009 Aug; 48(31):7525-32. PubMed ID: 19586056
[TBL] [Abstract][Full Text] [Related]
19. Use of short interfering RNA delivered by cationic liposomes to enable efficient down-regulation of PTPN22 gene in human T lymphocytes.
Perri V; Pellegrino M; Ceccacci F; Scipioni A; Petrini S; Gianchecchi E; Lo Russo A; De Santis S; Mancini G; Fierabracci A
PLoS One; 2017; 12(4):e0175784. PubMed ID: 28437437
[TBL] [Abstract][Full Text] [Related]
20. Protein tyrosine phosphatase PTPN22 in human autoimmunity.
Vang T; Miletic AV; Bottini N; Mustelin T
Autoimmunity; 2007 Sep; 40(6):453-61. PubMed ID: 17729039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
